These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Endocrine components in pathogenesis and clinico-metabolic evolution of dyspurinia in primary gout and its therapy]. Butturini U; Coscelli C; Palmari V Recenti Prog Med; 1971 Oct; 51(4):359-408. PubMed ID: 5172411 [No Abstract] [Full Text] [Related]
24. [Clinical studies of gout. Problems in the areas outside the cities]. Narasaki K Geka Chiryo; 1970 Mar; 22(3):296-300. PubMed ID: 5467647 [No Abstract] [Full Text] [Related]
25. [New findings in the pathology and therapy of gout]. Lenoch F Fysiatr Revmatol Vestn; 1968 Dec; 46(6):321-32. PubMed ID: 5749829 [No Abstract] [Full Text] [Related]
26. [Therapy of hyperuricemia and gout]. Pöllmann G; Kullich W; Klein G Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417 [TBL] [Abstract][Full Text] [Related]
28. A population study of hyperuricaemia and gout in Japan--analysis of sex, age and occupational differences in thirty-four thousand people living in Nagano Prefecture. Akizuki S Ryumachi; 1982 Jun; 22(3):201-8. PubMed ID: 7123395 [No Abstract] [Full Text] [Related]
29. [Uric acid and diabetes mellitus]. Kostrzewa-Zabłocka E Przegl Lek; 2004; 61(9):945-6. PubMed ID: 15803905 [No Abstract] [Full Text] [Related]
30. [Improvement of gout prognosis by suitable therapy]. Zöllner N; Gröbner W Lebensversicher Med; 1971 Nov; 23(6):125-7. PubMed ID: 4400590 [No Abstract] [Full Text] [Related]
31. [Basic therapy of gout by benziodarone]. Ryckewaert A; Kuntz D; Henrard JC; Puel M; de Seze S Presse Med (1893); 1969 Jul; 77(33):1157-60. PubMed ID: 4978390 [No Abstract] [Full Text] [Related]
33. [On the influence of Anturan on ric acid and plasma lipids in patients with gout]. Günther R; Herbst M; Knapp E; Siller K Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866 [No Abstract] [Full Text] [Related]